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Abstract Optical coherence tomography (OCT) is an optical
technique that measures the backscattering of near-infrared
light by tissue. OCT yields in 2D and 3D images at
micrometer-scale resolution, thus providing optical biopsies,
approaching the resolution of histopathological imaging. The
technique has shown to allow in vivo differentiation between
benign and malignant epithelial tissue, through qualitative
assessment of OCT images, as well as by quantitative evalu-
ation, e.g., functional OCT. This study aims to summarize the
principles of OCT and to discuss the current literature on the
diagnostic value of OCT in the diagnosis of epithelial (pre)
malignant lesions. The authors did a systematic search of the
electronic databases PubMed and Embase on OCT in the
diagnostic process of (pre)malignant epithelial lesions. OCT
is able to differentiate between benign and (pre)malignant
lesions of epithelial origin in a wide variety of tissues. In this
way, OCT can detect skin cancers, oral, laryngeal, and esoph-
ageal cancer as well as genital and bladder cancer. OCT is an
innovative technique which enables an optical biopsy of epi-
thelial lesions. The incorporation of OCT in specific tools, like
handheld and catheter-based probes, will further improve the
implementation of this technology in daily clinical practice.
Keywords Optical coherence tomography . Epithelial
cancers . Imaging
Introduction
More than 80 % of all cancers originate from the epithelium
[1]. Current methods of diagnosing these cancers rely on
histological and cytological examination of tissue or body
fluids. For this purpose, brushes or biopsies are harvested,
which have to be fixed and stained before diagnosis. To
circumvent this time-intensive procedure, new optical imag-
ing modalities that enable real-time (pre)malignant lesions
detection in vivo are being investigated at the moment. Optical
coherence tomography (OCT) is a technology developed in
the early 1990s for ophthalmological applications [2, 3] and is
profoundly used in that setting. OCT is the optical equivalent
of ultrasound, using light instead of sound, to produce images
of tissue. Resolutions up to 1–2 μm can be achieved, being
100–250 times higher than high-resolution ultrasound [4] and
approaching that of microscopy. However, due to light scat-
tering by the sample, imaging depth is usually limited
to ∼2 mm. An image produced by OCT resembles the tissue
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architecture observed in histology and can therefore be con-
sidered as an “optical biopsy”. This “optical biopsy” has high
potential in epithelial tumor diagnosis as it is non-invasive and
real-time [4]. Moreover, functional quantitative information
can be extracted, i.e., flow information, layer thickness, and
attenuation coefficient of the OCT signal [5, 6]. Given the
match between OCT imaging and histology in epithelial tis-
sues, OCT can play an important role in the diagnosis of
tumorous lesions.
After our pioneering work in kidney cancer [7, 8], bladder
cancer [9], and premalignant vulvar intraepithelial neoplasia
[10], we aim to review the diagnostic potential of OCT in
(pre)cancerous lesions of the human epithelium. As most
investigators study qualitative OCT, we focus on qualitative,
morphological imaging of human epithelium, especially of
the skin, the oropharyngeal and laryngeal area, the esopha-
gus, the genital area, and the bladder. At the end, we focus on
quantitative, e.g., functional OCT and we outline the poten-
tial future application of functional OCT imaging in diag-
nosing (pre)cancer.
Background of technique
OCT is based on depth resolved detection of elastic light
scattering. When light is directed at a tissue sample, it will
be partially back scattered. This back-scattered light is mea-
sured at different depths at a particular location on the tissue
using low-coherence interferometry resulting in a reflection
profile in the depth (z−) direction. The magnitude of the OCT
signal at each depth is determined by the different cellular
structures in the imaged volume (typically in the order of
103μm3 or 1 pl) and as a result it differs per tissue type.
Several adjacent depth profiles can be acquired in the lateral
(x−) direction and displayed as a gray-scale image in real time
which is known as an OCT B scan. Subsequently, the OCT
beam can be scanned across a tissue sample in the other lateral
(y−) direction, resulting in a 3D image representation with
acquisition speed reported up to several volumes per second.
System setup
The OCT system (Fig. 1) consists of an interferometer, gener-
ally constructed from fiber optic components, illuminated by a
broad wavelength–range light source operating in the near-
infrared (typically 1,250–1,350 nm for non-ophthalmic appli-
cations). A small fraction of the light is guided towards a
“reference” mirror; the majority is directed to the tissue, using
handheld XY-scanning devices or miniaturized endoscopic
probes (Fig. 2). Both fractions are combined and directed
towards a detection unit and subsequent computer processing.
Disposable in vivo OCT probes with a diameter less than 1 mm
are developed and already used in several medical settings,
enabling OCT to be used in endoscopes or in combination with
16G/18G needles to access internal tissue. Clinical value of
OCT images depends on obvious factors such as high resolu-
tion, high-imaging speed, and adequate contrast to discriminate
between benign and malignant tissues.
Contrast in OCT is caused by spatial differences in refrac-
tive index of different tissue constituents, e.g., contrast origi-
nates from reflection of different structures. It is known that
the refractive index is proportional to the density of the cells
and cell structure. Because malignant cells display an in-
creased number, larger and more irregularly shaped nuclei
with a higher refractive index and more active mitochondria,
OCT images are expected to be different in malignant tissue
compared to normal and benign tissue [11].
Methods
For this systematic review, we performed a literature search
using PubMed and Embase for original and review articles
Fig. 1 Schematic overview of
the OCT system. An optical
beam (from the light source) is
split into two arms. One arm is
directed at the tissue (scanning
sample arm), the other at a
mirror (the reference arm). The
reflected light from these two
paths is recombined and the
differences between these two
paths can be shown in a
greyscale image
1298 Lasers Med Sci (2014) 29:1297–1305
written in English, French, or German using the search
terms optical coherence tomography and skin cancer or
melanoma (rendering 85 and 16 articles, respectively),
optical coherence tomography and oral, pharyngeal, or
laryngeal cancer (rendering 30 and 8 articles, respectively),
optical coherence tomography and esophageal diseases
(rendering 74 and 27 articles, respectively).Optical coherence
tomography and urinary bladder, vulvar, cervical, or penile
cancer (rendering 95 and 42 articles, respectively) This search
resulted in a total of 377 hits, from which we selected 57
articles based on relevant contribution in describing technol-
ogy and clinical evaluation of these methods in skin cancer,
oral, laryngeal and esophageal cancer and genital and bladder
cancer. Selected articles originated from 1991 to 2012.
Results
Skin cancer
Nonmelanoma skin cancer
Nonmelanoma skin cancer (NMSC), including basal cell
carcinomas (BCC), squamous cell carcinomas (SCC), and
the premalignant actinic keratosis (AK), is the most preva-
lent cancer in light-skinned populations [12]. OCT could
benefit the diagnostic management of NMSC, especially in
patients with multiple lesions or lesions at locations where
resection results in bad cosmetic outcome [13].
Several studies are performed to assess whether OCT is
useful in diagnosing tumors and defining tumor borders
[14–20]. Olmedo et al. investigated 27 patients with
BCC. In 20 of them, the OCT images matched with histo-
pathology. A typical OCT image of BCC is shown in
Fig. 3a. In these images, the dark lobules representing BCC
appeared as a reflection density of the epidermis. A decreased
reflectance was seen around the periphery of the lobules of the
tumor, while the fibrous stroma closely surrounding the BCC
showed increased intensity. For the seven specimens that did
not match, technical issues had interfered with the examina-
tion [18]. Gambichler et al. imaged BCC as well as healthy
skin. In OCT images, healthy skin showed layered skin archi-
tecture, whereas BCC showed loss of these layers and disar-
rangement of the epidermis and dermis [14]. Absence of well-
defined layering in NMSC has been seen by others as well
[16, 20]. Mogensen et al. compared OCT directly to the
accuracy of pathology diagnosis. Depending on the observers,
sensitivity and specificity varied from 57 to 94 % and 43 to
96 %, respectively. Experienced observers reached a sensitiv-
ity of 79 to 94 % and a specificity of 85 to 96 % [16]. Instead
of observing the OCT images, Jorgensen et al. implemented a
machine-learning analysis. Correct classification of 37 AK
lesions and 41 BCCs compared to pathology were made with
an accuracy of 73% (AK) and 81% (BCC) [15]. Other studies
focused on measuring the thickness of BCC [19] and AK [17]
in vivo. A strong correlation between tumor thickness mea-
sured in both OCT and pathology was found (p<0.001) [19].
Overall, OCT is able to show the different skin layers and is
capable to measure tumor thickness in NMSC.
Malignant melanoma
In case of a malignant melanoma (MM), thickness is the
most important factor for (a) staging, (b) determining the
size of the excision margins, and (c) the need for sentinel
lymph node biopsy. Using OCT to measure MM thick-
ness could enable better preoperative planning by defin-
ing resection margins and the need for sentinel lymph
node biopsy. Moreover, a non-invasive diagnostic tool
capable of distinguishing between benign nevi (BN)
and MM would decrease the amount of unnecessary
harvested biopsies and excisions. Histopathologically,
MM consists of atypical melanocytes (with atypical nu-
clei and nucleoli) that invade the epidermis and some-
times even invade the dermis. These atypical cells may
have a different nuclear refractive index and thus lead to
difference in scattering [11]. A typical OCT image of
MM is shown in Fig. 3b.
Fig. 2 Clinical OCT system employed at our medical center. Left
shows the system on a cart allowing the system to be transferred from
different clinical settings easily. The system can be interfaced with
either an x/y scanning handheld device (upper right) or a rotating
endoscopic scanning device (lower right). The latter scans its environ-
ment by fast rotational (lighthouse like) movements. 3D imaging in
this case is achieved by a pullback of the probe
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Only a few studies are performed to investigate whether
OCT is useful in detecting MM. De Giorgi et al. studied the
pigment network and brown globules in melanocytic
pigmented lesions as seen with dermatoscopy [21] and com-
pared these features with OCT and histology. In 6 out of 10
cases, it was possible to compare structures found in
dermatoscopy and histology to structures in OCT. However,
it was impossible to differentiateMM fromBN. On contrary, a
study by Gambichler et al. showed significant differences in
OCT imaging of BN and MM [22]. A total of 75 patients with
52 BN and 40 MM were included. MM showed a marked
architectural disarray (p=0.036) and rarely displayed a clear
dermo-epidermal border (p=0.0031) when compared to BN.
The most prominent OCT feature of MM was large, vertical
cone-shaped structures, which were not observed in BN
(p<0.001) [22]. Although these results are promising, a large
Fig. 3 OCT vs. histology of several epithelial lesions
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clinical study is needed to establish robust differentiation of
melanoma from benign nevi.
Oral, laryngeal, and esophageal cancer
Oral cancer
SCC, accounting for 96 % of all oral cancers, is mostly
preceded by dysplasia presenting as white or red lesions
on the oral mucosa (leukoplakia, erythroplakia). Currently,
these potentially malignant lesions are biopsied or excised
and therefore less suitable for screening of high-risk popu-
lation. Only a few studies have been performed on OCT in
the oral cavity. One of these studies included 143 healthy
volunteers and demonstrated a varying thickness of epithe-
lium depending on its location within the oral cavity. The
largest thickness values were measured in the region of the
buccal mucosa and the hard palate, whereas the thinnest
epithelium was found at the floor of the mouth [23].
Wilders-Smith et al. imaged 50 patients with oral suspicious
lesions with OCT, shown in Fig. 3c. After imaging, standard
biopsy and histopathology were performed. Two investiga-
tors diagnosed the lesions blinded on OCT and histopathol-
ogy subsequently. For detecting carcinoma in situ or SCC
versus noncancer, sensitivity was 0.931 and specificity was
0.931; for detecting SCC versus all other pathologies, sen-
sitivity was 0.931 and specificity was 0.973 [24]. Another
study showed differences between normal oral mucosa,
dysplasia and SCC scoring the OCT images on three in-
dicators: epidermal layer thickness, standard deviation of an
A-mode scan intensity profile in the epidermal layer, and the
attenuation of light. However, the clinical value of this study
is limited due to unclear methodology [25]. Recently,
Adegun et al. measured the backscattered light intensity as
a function of depth in OCT images of biopsy samples from
the oral cavity. Hereby, they could differentiate dysplasia
from normal control samples [26]. Overall, OCT seems to
differentiate well between normal tissue and SCC.
Laryngeal cancer
Several studies in the human larynx have been performed. In
a study of 82 patients undergoing surgery for various head
and neck pathology, OCT provided information on epithe-
lial layer thickness, integrity of the basement membrane
(BM), and microstructural features. Whereas the normal
epithelial thickness varied from 98 to 185 μm, the epithelial
layer was thickened up to 300 μm in hyperkeratotic lesions.
In hyperkeratotic lesions, the BM on OCT images was still
intact in contrary to early microinvasive SCC of the larynx,
where disruption of the BM was seen on OCT images.
Moreover, OCT images were comparable with conventional
histopathology [27].
Esophageal cancer
Over the past two decades, the incidence of esophageal
adenocarcinoma (AC) has risen considerably, especially in
the distal esophagus and the esophagogastric junction. Sev-
eral studies showed that gastro-esophageal reflux disease
increases the risk of getting esophageal AC [28] by promot-
ing the formation of Barret’s esophagus (BE), a precursor of
AC. At the moment, endoscopy and random taken biopsies
are used to follow up patients with BE. Endoscopic OCT
might be helpful in selecting suspicious areas in BE for
further biopsy.
The use of OCT in imaging the esophagus and the
esophagogastric junction has been widely studied. Ex-vivo
studies showed that OCT can differentiate diverse layers in
the esophageal wall [29] and can generate images corre-
sponding to histology [30, 31]. Poneros et al. formulated
different criteria for intestinal metaplasia on the basis of
OCT images. When tested prospectively, these criteria had
a sensitivity of 97 % and a specificity of 92 % [32]. Like-
wise, others acquired OCT images of the esophagus and
stomach in 69 patients containing normal squamous muco-
sa, BE and AC. These OCT images were accurately recog-
nized by observers unaware of their site of origin, with an
accuracy of 84.6 % [33]. Isenberg determined the accuracy
of endoscopic OCT in diagnosis of dysplasia in patients
with BE. They reported an accuracy of 78 % for the detec-
tion of dysplasia in BE. Main limitations of the study were
the variability in endoscopists’ accuracy rates, difficulty in
real-time interpretation, and the need for refined criteria of
dysplasia in endoscopic OCT imaging [34]. OCT of dyspla-
sia was studied in more detail by Evens et al. They studied
biopsy-correlated OCT images to establish OCT image char-
acteristics able to differentiate intramucosal carcinoma
(ICM) and high-grade dysplasia (HGD) from low-grade
Fig. 3 (continued)
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dysplasia, because ICM and HGD have a higher risk of
developing into AC. There was a significant relationship
between the histopathological diagnosis of IMC/HGD and
the scores for each OCT image feature [35]. Recent improve-
ments in endoscopic OCT made it possible to image larger
areas such as the entire distal esophagus (approximately
6.0 cm) with ultrahigh resolution [36, 37]. An example of a
typical OCT image of the esophagus is given in Fig. 3d. With
this approach, it may be possible to accurately define patients
with dysplasia who are at risk for developing AC.
Genital and bladder cancer
Vulvar cancer
In the last 30 years, the incidence of vulvar intraepithelial
neoplasia (VIN), a premalignant skin disorder that often
causes pruritus, pain and psychosexual dysfunction, has
increased more than 400 % to approximately 2.5 cases per
100,000 women in the USA. The progression rate of VIN
into VSCC is about 9 % in untreated patients and 3.3 % in
patients after treatment. VIN is treated using conservative
surgical excision, laser vaporization, or medical therapy.
Patients are regularly examined to foresee occult invasion
and check for possible new VIN lesions [38]. Definite
diagnosis of a vulvar lesion of uncertain significance is
obtained by punch biopsy. However, every attempt is made
to avoid vulvar mutilation that may lead to psychosexual
distress [39, 40]. Hence, in the present workflow in the
diagnosis and treatment of VIN, there is a clear need for
non-invasive diagnostic tools.
In a study by Escobar et al., three patients with Paget’s
disease (a potential premalignant lesion) were imaged with
OCT [41]. The authors observed clear irregularities in the
epithelial layer and disruption of the basal membrane. Be-
sides disruption of the basement membrane, OCT may be
helpful in characterization of vulvar lesions by demonstrat-
ing differences in layer thickness and in the attenuation of
light between different tissues. Data from our group in 16
patients with VIN show a significant difference in the thick-
ness of the epidermal layer as well as in the attenuation of
light between VIN lesions and healthy skin [10]. These
differences probably occur because of the growth of neo-
plastic cells and changed nuclear/cytoplasma ratio in VIN
lesions compared with healthy cells [11]. These data indi-
cate the potential of OCT to distinguish between healthy and
VIN lesions. In Fig. 3e, an example of an OCT image of a
VIN lesion is shown.
Cervical cancer
Cervical cancer is generally preceded by intraepithelial neo-
plasia (CIN). Hence, the implementation of new imaging
techniques that allow cheap, real-time, and non-invasive
detection of premalignant abnormalities have the potential
to improve the logistics and economics of screening pro-
grams for invasive cervical cancer [41, 42].
The diagnostic value of OCT in the detection of CIN has
been studied by several groups. In 1999, the first ex vivo
study on 32 cervical specimens concluded that an intact
basement membrane—a feature of healthy epithelium in
histology—can be seen with OCT [43]. The first in vivo
studies were performed by Escobar et al. [41]. OCT images of
patients with CIN I, II, and III lesions were directly compared
to histology reports. All images of normal cervix showed a
clear epithelial layer and a basal membrane that was defined as
an interface between a brighter scattering (stroma) and a
poorer scattering (epithelium) region in the OCT image. The
authors concluded that this pattern presented normal squa-
mous epithelium. In 16 of the 18 patients with CIN II and/or
III, the images showed an unstructured homogenous area with
highly backscattering region and fast attenuation of the signal;
however, this was not quantified. This correlation between the
intensity of the backscattering light from the epithelia of
normal and abnormal tissue in the cervix, was also found by
others [44]. To determine further accuracy of the OCT images,
a grading scale was used to describe the OCT images: normal
if a well-organized two-layered structure was seen with a
sharp interface between the surface epithelium (squamous)
and underlying layer (connective tissue); abnormal if the
tissue was unstructured with no interface present and interme-
diate if irregularities on the images suggested artifacts or
physiological conditions that did not meet the criteria. With
this grading scale, sensitivity and specificity of OCT alone for
≥CIN II lesions was 56 and 59 %, respectively [45].
If patients with positive cervix cytology for dysplastic
cells undergo colposcopy, OCT might have the potential to
predict if a specific spot seen with colposcopy is CIN I, II,
III or invasive cancer. In this setting, Liu investigated OCT
imaging in colposcopy. OCT decreased the sensitivity to
detect ≥CIN II lesions form 63 to 36 %; however, specificity
increased from 83 to 93 % [46]. To improve clinical analy-
sis, Lee looked at the degrees of circular polarization caused
by the scattering changes induced by CIN. A linear fitting
procedure was used to quantify the attenuation of the
degrees-of-polarization signal. This approach resulted in
sensitivity and specificity to detect CIN of 94.7 and
71.2 %, respectively [47]. An OCT image of a CIN I lesion
is shown in Fig. 3f. Further improvements in OCT resolu-
tion are currently tested to improve accuracy of OCT for
diagnosing cervical cancer and CIN.
Bladder cancer
In nondiseased tissue, the three anatomic layers of the bladder
wall (urothelium, lamina propria, and muscularis propria) can
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be well distinguished with OCT [48, 49]. Hermes et al. eval-
uated OCT in 142 human bladder specimens ex vivo and
demonstrated that OCT could discriminate between normal,
CIS and invasive transitional cell carcinoma (TCC) with a
sensitivity of 83.8 % and a specificity of 78.1 %. None of the
CIS or TCC samples was classified as normal tissue based on
the OCT image (no false-negatives), 6 samples of normal
tissue were classified as TCC (false-positive rate 5.7 %), and
24 samples could not be classified (16.9 %) [50]. Two groups
investigated the diagnostic accuracy of cystoscopic applied
OCT. Manyak et al. classified bladder tissue samples as be-
nign or malignant with an overall sensitivity and specificity of
100 and 89 %, respectively. Ten malignancies were classified
by OCT as invasive (≥T1), of which nine were confirmed by
histology [51]. Lerner et al. showed that differentiation of
bladder tumors confined to the mucosa (Ta) was possible with
a sensitivity of 90 % and a specificity of 89 %. For differen-
tiation of T1 and T2 tumors, sensitivity was 75 and 100 %,
while specificity was 97 and 90 % [52]. False-positive find-
ings could generally be explained by inflammatory lesions of
the bladder [51].
Lingley-Papadopoulos et al. developed an automated algo-
rithm that allows recognition of texture within an OCT image
to provide the urologist with a diagnosis. This algorithm was
able to differentiate benign and malignant bladder tissue with
a sensitivity of 92 % and a specificity of 62 % [53].
Since real-time high-resolution OCT images can be
obtained during cystoscopy, the technique may especially
be useful for guidance of biopsy procedures and staging of
suspected tissue areas within the bladder. In Fig. 3g, an OCT
image of a papillary carcinoma of the bladder is shown.
Discussion and conclusions
OCT is an optical diagnostic tool that aims to predict in
vivo histopathologic diagnosis in a non-invasive way. It pro-
duces real-time high-resolution images comparable with his-
topathology. Several studies have shown that OCT can be
used to distinguish healthy skin from NMSC. For detection
of melanoma lesions, however, the accuracy is still limited. In
the oral cavity and larynx, OCT is able to distinguish between
normal tissue and SCC. In addition, OCTcan give information
about tissue thickness and basement membrane integrity. Dif-
ferentiation between dysplasia and normal can still be im-
proved. In the esophagus, large areas with high resolution
can be imaged allowing tissue characterization of dysplasia
as well as tumor tissue. For vulva lesions, OCT proved to be
able to differentiate between healthy tissue and VIN lesions,
while in the cervix OCT allowed differentiation between
normal cervical tissue and CIN. However, OCT is not capable
of distinguishing different CIN grades. Bladder OCT so far
has shown the potential to differentiate grade and stage in
small populations but it needs a larger population study to
provide definite answers.
Future perspectives
OCT holds the potential to provide functional optical biopsies
of epithelial cancers by combining imaging with quantification
of physiological functional parameters, e.g., perfusion and ox-
ygenation or cellular organization. This can be achieved either
by advanced analysis of the OCT signal itself [54, 55] or by
combining OCTwith other imaging modalities such as Raman
spectroscopy (RS) [56] or fluorescence spectroscopy [57].
Analysis of the spatial and temporal changes of the OCTsignal
allows determination of the optical attenuation coefficient
(which is related to tissue organization) and blood perfusion.
We have demonstrated that the attenuation coefficient discrim-
inates between normal and (pre)cancerous lesions in vulva [10],
bladder [9], and kidney [7, 8]. Advanced implementations of
OCT use light that is extended from the near infrared to the
visible wavelengths, allowing quantification of hemoglobin
concentrations [58] and oxygen saturation ultimately allowing
to map oxygen metabolism of individual locations in the lesion.
Complementary information on biochemical composition can
be obtained by combining OCT with RS. In that way, RS can
estimate the molecular composition of tissue, while OCT can
produce images. The use of OCT in combination with other
techniques can hereby assist in screening and eventually even
diagnose malignancies non-invasively.
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